• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Defining Cancer Subtypes With Distinctive Etiologic Profiles: An Application to the Epidemiology of Melanoma.定义具有独特病因学特征的癌症亚型:在黑色素瘤流行病学中的应用
J Am Stat Assoc. 2017;112(517):54-63. doi: 10.1080/01621459.2016.1191499. Epub 2017 May 3.
2
Genomic investigation of etiologic heterogeneity: methodologic challenges.病因异质性的基因组研究:方法学挑战
BMC Med Res Methodol. 2014 Dec 22;14:138. doi: 10.1186/1471-2288-14-138.
3
Identifying Etiologically Distinct Sub-Types of Cancer: A Demonstration Project Involving Breast Cancer.识别癌症的病因学不同亚型:一项涉及乳腺癌的示范项目
Cancer Med. 2015 Sep;4(9):1432-9. doi: 10.1002/cam4.456. Epub 2015 May 13.
4
A conceptual and methodological framework for investigating etiologic heterogeneity.一种用于研究病因异质性的概念和方法学框架。
Stat Med. 2013 Dec 20;32(29):5039-52. doi: 10.1002/sim.5902. Epub 2013 Jul 16.
5
Validity of a method for identifying disease subtypes that are etiologically heterogeneous.一种用于识别病因异质性疾病亚型的方法的有效性。
Stat Methods Med Res. 2021 Sep;30(9):2045-2056. doi: 10.1177/09622802211032704. Epub 2021 Jul 28.
6
Occupation and cancer - follow-up of 15 million people in five Nordic countries.职业与癌症 - 五个北欧国家的 1500 万人随访研究。
Acta Oncol. 2009;48(5):646-790. doi: 10.1080/02841860902913546.
7
Defining etiologic heterogeneity in breast cancer using genetic biomarkers.利用基因生物标志物定义乳腺癌的病因异质性。
Prog Clin Biol Res. 1997;396:53-61.
8
polyClustR: defining communities of reconciled cancer subtypes with biological and prognostic significance.polyClustR:定义具有生物学和预后意义的协调癌症亚型群落。
BMC Bioinformatics. 2018 May 25;19(1):182. doi: 10.1186/s12859-018-2204-4.
9
Breast cancer biologic and etiologic heterogeneity by young age and menopausal status in the Carolina Breast Cancer Study: a case-control study.卡罗来纳乳腺癌研究中按年龄和绝经状态划分的乳腺癌生物学及病因异质性:一项病例对照研究
Breast Cancer Res. 2016 Aug 4;18(1):79. doi: 10.1186/s13058-016-0736-y.
10
Progestin-only and combined oral contraceptives and receptor-defined premenopausal breast cancer risk: The Norwegian Women and Cancer Study.仅孕激素避孕药和复方口服避孕药与受体定义的绝经前乳腺癌风险:挪威妇女与癌症研究。
Int J Cancer. 2018 Jun 1;142(11):2293-2302. doi: 10.1002/ijc.31266. Epub 2018 Feb 7.

引用本文的文献

1
Melanocyte lineage dynamics in development, growth and disease.黑素细胞谱系在发育、生长和疾病中的动态变化。
Development. 2024 Aug 1;151(15). doi: 10.1242/dev.201266. Epub 2024 Aug 2.
2
Validity of a method for identifying disease subtypes that are etiologically heterogeneous.一种用于识别病因异质性疾病亚型的方法的有效性。
Stat Methods Med Res. 2021 Sep;30(9):2045-2056. doi: 10.1177/09622802211032704. Epub 2021 Jul 28.
3
Risk factors for melanoma by anatomical site: an evaluation of aetiological heterogeneity.按解剖部位划分的黑色素瘤危险因素:病因异质性评估
Br J Dermatol. 2021 Jun;184(6):1085-1093. doi: 10.1111/bjd.19705. Epub 2021 Feb 18.
4
Family Study Designs Informed by Tumor Heterogeneity and Multi-Cancer Pleiotropies: The Power of the Utah Population Database.基于肿瘤异质性和多癌多效性的家系研究设计:犹他州人口数据库的作用
Cancer Epidemiol Biomarkers Prev. 2020 Apr;29(4):807-815. doi: 10.1158/1055-9965.EPI-19-0912. Epub 2020 Feb 25.
5
Evidence for Etiologic Subtypes of Breast Cancer in the Carolina Breast Cancer Study.卡罗来纳乳腺癌研究中的乳腺癌病因亚型证据。
Cancer Epidemiol Biomarkers Prev. 2019 Nov;28(11):1784-1791. doi: 10.1158/1055-9965.EPI-19-0365. Epub 2019 Aug 8.

本文引用的文献

1
Association of Interferon Regulatory Factor-4 Polymorphism rs12203592 With Divergent Melanoma Pathways.干扰素调节因子4基因多态性rs12203592与不同黑色素瘤通路的关联
J Natl Cancer Inst. 2016 Feb 8;108(7). doi: 10.1093/jnci/djw004. Print 2016 Jul.
2
Association Between NRAS and BRAF Mutational Status and Melanoma-Specific Survival Among Patients With Higher-Risk Primary Melanoma.NRAS 和 BRAF 基因突变状态与高危原发性黑色素瘤患者的黑色素瘤特异性生存之间的关联。
JAMA Oncol. 2015 Jun;1(3):359-68. doi: 10.1001/jamaoncol.2015.0493.
3
A Meta-Regression Method for Studying Etiological Heterogeneity Across Disease Subtypes Classified by Multiple Biomarkers.一种用于研究由多种生物标志物分类的疾病亚型间病因异质性的Meta回归方法。
Am J Epidemiol. 2015 Aug 1;182(3):263-70. doi: 10.1093/aje/kwv040. Epub 2015 Jun 26.
4
Identifying Etiologically Distinct Sub-Types of Cancer: A Demonstration Project Involving Breast Cancer.识别癌症的病因学不同亚型:一项涉及乳腺癌的示范项目
Cancer Med. 2015 Sep;4(9):1432-9. doi: 10.1002/cam4.456. Epub 2015 May 13.
5
Inherited genetic variants associated with occurrence of multiple primary melanoma.与多发性原发性黑色素瘤发生相关的遗传变异。
Cancer Epidemiol Biomarkers Prev. 2015 Jun;24(6):992-7. doi: 10.1158/1055-9965.EPI-14-1426. Epub 2015 Apr 2.
6
A robust association test for detecting genetic variants with heterogeneous effects.一种用于检测具有异质性效应的基因变异的稳健关联检验。
Biostatistics. 2015 Jan;16(1):5-16. doi: 10.1093/biostatistics/kxu036. Epub 2014 Jul 23.
7
Association between BRAFV600E and NRASQ61R mutations and clinicopathologic characteristics, risk factors and clinical outcome of primary invasive cutaneous melanoma.BRAFV600E与NRASQ61R突变之间的关联以及原发性侵袭性皮肤黑色素瘤的临床病理特征、危险因素和临床结局
Cancer Causes Control. 2014 Oct;25(10):1379-86. doi: 10.1007/s10552-014-0443-x. Epub 2014 Jul 22.
8
A conceptual and methodological framework for investigating etiologic heterogeneity.一种用于研究病因异质性的概念和方法学框架。
Stat Med. 2013 Dec 20;32(29):5039-52. doi: 10.1002/sim.5902. Epub 2013 Jul 16.
9
Breast cancer risk prediction with heterogeneous risk profiles according to breast cancer tumor markers.根据乳腺癌肿瘤标志物的异质风险特征预测乳腺癌风险。
Am J Epidemiol. 2013 Jul 15;178(2):296-308. doi: 10.1093/aje/kws457. Epub 2013 May 3.
10
A comparison of the polytomous logistic regression and joint cox proportional hazards models for evaluating multiple disease subtypes in prospective cohort studies.在前瞻性队列研究中评估多种疾病亚型的多项逻辑回归和联合 Cox 比例风险模型比较。
Cancer Epidemiol Biomarkers Prev. 2013 Feb;22(2):275-85. doi: 10.1158/1055-9965.EPI-12-1050. Epub 2013 Jan 4.

定义具有独特病因学特征的癌症亚型:在黑色素瘤流行病学中的应用

Defining Cancer Subtypes With Distinctive Etiologic Profiles: An Application to the Epidemiology of Melanoma.

作者信息

Mauguen Audrey, Zabor Emily C, Thomas Nancy E, Berwick Marianne, Seshan Venkatraman E, Begg Colin B

机构信息

Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, NY.

Department of Dermatology, University of North Carolina, Chapel Hill, NC.

出版信息

J Am Stat Assoc. 2017;112(517):54-63. doi: 10.1080/01621459.2016.1191499. Epub 2017 May 3.

DOI:10.1080/01621459.2016.1191499
PMID:28603323
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5460661/
Abstract

We showcase a novel analytic strategy to identify sub-types of cancer that possess distinctive causal factors, i.e. sub-types that are "etiologically" distinct. The method involves the integrated analysis of two types of study design: an incident series of cases with double primary cancers with detailed information on tumor characteristics that can be used to define the sub-types; a case-series of incident cases with information on known risk factors that can be used to investigate the specific risk factors that distinguish the sub-types. The methods are applied to a rich melanoma dataset with detailed information on pathologic tumor factors, and comprehensive information on known genetic and environmental risk factors for melanoma. Identification of the optimal sub-typing solution is accomplished using a novel clustering analysis that seeks to maximize a measure that characterizes the distinctiveness of the distributions of risk factors across the sub-types and that is a function of the correlations of tumor factors in the case-specific tumor pairs. This analysis is challenged by the presence of extensive missing data. If successful, studies of this nature offer the opportunity for efficient study design to identify unknown risk factors whose effects are concentrated in defined sub-types.

摘要

我们展示了一种新颖的分析策略,用于识别具有独特因果因素的癌症亚型,即 “病因学上” 不同的亚型。该方法涉及对两种研究设计的综合分析:一种是具有双原发性癌症的病例发病系列,带有可用于定义亚型的肿瘤特征详细信息;另一种是具有已知风险因素信息的发病病例系列,可用于研究区分这些亚型的特定风险因素。这些方法应用于一个丰富的黑色素瘤数据集,该数据集包含病理肿瘤因素的详细信息以及黑色素瘤已知遗传和环境风险因素的全面信息。使用一种新颖的聚类分析来确定最佳亚型解决方案,该分析旨在最大化一个衡量指标,该指标表征风险因素在各亚型间分布的独特性,并且是特定病例肿瘤对中肿瘤因素相关性的函数。这种分析受到大量缺失数据的挑战。如果成功,此类研究为高效研究设计提供了机会,以识别其影响集中在特定亚型中的未知风险因素。